SCHEMBL9256001

SCHEMBL9256001

Nc1ccc(-n2sc(-c3ccccc3)cc2=O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
MAPT P10636 4/20 0.40
PKM P14618 2/20 0.40
LMNA P02545 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CYP3A4 P08684 2/20 0.39
HSD17B10 Q99714 2/20 0.39
TAAR1 Q96RJ0 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
KAT2B Q92831 4/20 0.38
PABPC1 P11940 1/20 0.38
CASP3 P42574 1/20 0.38
CASP7 P55210 1/20 0.38
CASP9 P55211 1/20 0.38
CASP6 P55212 1/20 0.38
SMN1; SMN2 Q16637 5/20 0.38
CYP1A2 P05177 2/20 0.37
IKBKB O14920 1/20 0.37
CYP2C9 P11712 1/20 0.37
BTK Q06187 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9263852 0.85 PHOSPHO1 (0.47) KDM4EMAPTPKMHSD17B10TDP1
SCHEMBL9262493 0.81 MAPT (0.46) KDM4EMAPTPKMTDP1SMN1; SMN2
SCHEMBL9258084 0.78 ALDH1A1 (0.43) KDM4EMAPTPKMLMNAKAT2B
SCHEMBL9265563 0.77 KDM4E (0.40) KDM4EMAPTPKMLMNARXFP1
SCHEMBL9256085 0.75 PMM2 (0.45) KDM4EMAPTPKMHSD17B10TDP1
SCHEMBL9263510 0.75 SMN1; SMN2 (0.60) KDM4EMAPTLMNAHSD17B10TDP1
SCHEMBL9260520 0.71 NR1H3 (0.33) KAT2B
SCHEMBL8080054 0.70 HSD17B10 (0.41) KDM4EMAPTPKMLMNAHSD17B10
SCHEMBL9265797 0.69 MYC (0.45) KDM4EMAPTTDP1RAB9AALDH1A1
SCHEMBL9256371 0.67 ALDH1A1 (0.42) MAPTLMNACYP3A4TDP1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5411977-A Substituted 2,5-diaryl-4-isothiazolin-3-ones as antiinflammatory and antithrombotic agents THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1995-05-02 US disclosed